Model Details

Patient Information for Model: BCM-15030

Patient Information
Clinical Timeline

Color Keys:
 
 Positive
 
 Negative
 
 N/A

Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection

Model Information for Model: BCM-15030

Model Details - Initial Implantation of Patient Tissue
Biomarkers & Mutations
Model Details - Acceptable Conditions for Passaging
Mutations (Cancer Gene Census List)
Mutation data is currently not available.

CNV


Histology Information for Model: BCM-15030

Patient

PDX


Metastasis Information for Model: BCM-15030
 
Patient
PDX
Abdomen
Abdominal cavity
Adrenal Gland
Anterosuperior mediastinum
Ascites
Axillary Lymph Node
Bone
Brain
CTC
Chest
Chest wall
Contralateral Breast
Fallopian tubes
Head
Hilar Node
Hip
Kidney
Leg bone
Leptomeninges
Liver
Lung
Lymph Node
Mediastinum
Metastasis Pleura
Neck
None
Other
Ovary
Pancreas
Paratracheal adenopathy
Pericardium
Peritoneal cavity
Peritoneum
Pleura
Pleural cavity
Pleural effusion
Posterior cervical nodes
Pulmonary
Retrocrural Lymph Node
SVC node
Sacral Spine
Skin
Spine
Spleen
Thymus

Patient Treatment Information for Model: BCM-15030

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponsePathologic ResponseReason Stopped
10Fluorouracil, Doxorubicin, CyclophosphamideAdjuvant34.4234.75120 daysNot ReportedNot ApplicableTreatment Completed
20Other, TamoxifenRecurrent/Metastatic43.5948.761887 daysNot ReportedNot ApplicableDisease Progression
25Goserelin, AnastrozoleRecurrent/Metastatic49.0949.1833 daysNot ReportedNot ApplicableSide Effects
30Megestrol acetateRecurrent/Metastatic49.2655.522285 daysNot ReportedNot ApplicableDisease Progression
35FulvestrantRecurrent/Metastatic55.5256.77456 daysNot ReportedNot ApplicableDisease Progression
40LetrozoleRecurrent/Metastatic56.8557.0262 daysNot ReportedNot ApplicableDisease Progression
45TamoxifenRecurrent/Metastatic57.157.1829 daysNot ReportedNot ApplicableTreatment Completed
50OophorectomyRecurrent/Metastatic57.1857.18UnknownNot ReportedNot ApplicableTreatment Completed
55AnastrozoleRecurrent/Metastatic57.1957.77212 daysNot ReportedNot ApplicableDisease Progression
60Everolimus, ExemestaneRecurrent/Metastatic57.8358.0891 daysNot ReportedNot ApplicableSide Effects
65Palbociclib, LetrozoleRecurrent/Metastatic58.158.68212 daysNot ReportedNot ApplicableDisease Progression
70Radiation Therapy (RT)Recurrent/Metastatic58.6858.8147 daysNot ReportedNot ApplicableTreatment Completed
75AnastrozoleRecurrent/Metastatic58.7759.52274 daysNot ReportedNot ApplicableDisease Progression
80CapecitabineRecurrent/Metastatic59.6161.0507 daysNot ReportedNot ApplicableCurrent Treatment
95High-dose estrogenMetastatic60.961.037 daysProgressive DiseaseNot ApplicableDisease Progression














Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.